BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 12562511)

  • 1. Transmitter uptake and release in PC12 cells overexpressing plasma membrane monoamine transporters.
    Schonn JS; Desnos C; Henry JP; Darchen F
    J Neurochem; 2003 Feb; 84(4):669-77. PubMed ID: 12562511
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biogenic amine flux mediated by cloned transporters stably expressed in cultured cell lines: amphetamine specificity for inhibition and efflux.
    Wall SC; Gu H; Rudnick G
    Mol Pharmacol; 1995 Mar; 47(3):544-50. PubMed ID: 7700252
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ketamine inhibits monoamine transporters expressed in human embryonic kidney 293 cells.
    Nishimura M; Sato K; Okada T; Yoshiya I; Schloss P; Shimada S; Tohyama M
    Anesthesiology; 1998 Mar; 88(3):768-74. PubMed ID: 9523822
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reboxetine: functional inhibition of monoamine transporters and nicotinic acetylcholine receptors.
    Miller DK; Wong EH; Chesnut MD; Dwoskin LP
    J Pharmacol Exp Ther; 2002 Aug; 302(2):687-95. PubMed ID: 12130733
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protein kinase C-mediated translocation of secretory vesicles to plasma membrane and enhancement of neurotransmitter release from PC12 cells.
    Shoji-Kasai Y; Itakura M; Kataoka M; Yamamori S; Takahashi M
    Eur J Neurosci; 2002 Apr; 15(8):1390-4. PubMed ID: 11994133
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Functional expression of the plasma membrane serotonin transporter but not the vesicular monoamine transporter in human placental trophoblasts and choriocarcinoma cells.
    Prasad PD; Hoffmans BJ; Moe AJ; Smith CH; Leibach FH; Ganapathy V
    Placenta; 1996 May; 17(4):201-7. PubMed ID: 8761963
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lobeline analogs with enhanced affinity and selectivity for plasmalemma and vesicular monoamine transporters.
    Miller DK; Crooks PA; Zheng G; Grinevich VP; Norrholm SD; Dwoskin LP
    J Pharmacol Exp Ther; 2004 Sep; 310(3):1035-45. PubMed ID: 15121762
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of metaiodobenzylguanidine uptake by the norepinephrine, dopamine and serotonin transporters.
    Glowniak JV; Kilty JE; Amara SG; Hoffman BJ; Turner FE
    J Nucl Med; 1993 Jul; 34(7):1140-6. PubMed ID: 8315492
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transient developmental expression of monoamine transporters in the rodent forebrain.
    Lebrand C; Cases O; Wehrlé R; Blakely RD; Edwards RH; Gaspar P
    J Comp Neurol; 1998 Nov; 401(4):506-24. PubMed ID: 9826275
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cell-type-specific expression of catecholamine transporters in the rat brain.
    Lorang D; Amara SG; Simerly RB
    J Neurosci; 1994 Aug; 14(8):4903-14. PubMed ID: 8046459
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Further characterisation of the interaction of haloperidol metabolites with neurotransmitter transporters in rat neuronal cultures and in transfected COS-7 cells.
    Siebert GA; Pond SM; Bryan-Lluka LJ
    Naunyn Schmiedebergs Arch Pharmacol; 2000 Mar; 361(3):255-64. PubMed ID: 10731037
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fluctuation analysis of norepinephrine and serotonin transporter currents.
    DeFelice LJ; Galli A
    Methods Enzymol; 1998; 296():578-93. PubMed ID: 9779475
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Selective inhibition of monoamine neurotransmitter transporters by synthetic local anesthetics.
    Sato T; Kitayama S; Mitsuhata C; Ikeda T; Morita K; Dohi T
    Naunyn Schmiedebergs Arch Pharmacol; 2000 Feb; 361(2):214-20. PubMed ID: 10685879
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression cloning of a serotonin transporter: a new way to study antidepressant drugs.
    Hoffman BJ
    Pharmacopsychiatry; 1994 Jan; 27(1):16-22. PubMed ID: 8159777
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Function of monoamine neurotransmitter transporters].
    Sasa M
    Nihon Rinsho; 2001 Aug; 59(8):1457-64. PubMed ID: 11519142
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Norsalsolinol uptake into secretory vesicles via vesicular monoamine transporter and its secretion by membrane depolarization or purinoceptor stimulation in PC12 cells.
    Maruyama Y; Suzuki Y; Kazusaka A; Fujita S
    J Vet Med Sci; 2001 May; 63(5):493-7. PubMed ID: 11411492
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lanthanides inhibit the human noradrenaline, 5-hydroxytryptamine and dopamine transporters.
    Bryan-Lluka LJ; Bönisch H
    Naunyn Schmiedebergs Arch Pharmacol; 1997 Jun; 355(6):699-706. PubMed ID: 9205953
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The antidepressant-sensitive dopamine transporter in Drosophila melanogaster: a primordial carrier for catecholamines.
    Pörzgen P; Park SK; Hirsh J; Sonders MS; Amara SG
    Mol Pharmacol; 2001 Jan; 59(1):83-95. PubMed ID: 11125028
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Functional coupling of serotonin and noradrenaline transporters.
    Horschitz S; Hummerich R; Schloss P
    J Neurochem; 2003 Aug; 86(4):958-65. PubMed ID: 12887693
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Catecholamine reuptake and storage. Overview.
    Bönisch H; Eiden L
    Adv Pharmacol; 1998; 42():149-64. PubMed ID: 9327868
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.